Hindusthan Samachar
Banner 2 मंगलवार, अप्रैल 23, 2019 | समय 01:54 Hrs(IST) Sonali Sonali Sonali Singh Bisht

Wockhardt shares bounce on approval of Cancer drug by USFDA

By HindusthanSamachar | Publish Date: Apr 11 2019 3:51PM
Wockhardt shares bounce on approval of Cancer drug by USFDA
New Delhi, Apr.11(HS): A major bounce of 7.31 percent in share price of Wockhardt was noticed today on account of approval received from US Food and Drug Administration(USFDA) for its cancer drug-Decitabine yesterday. This share has outperformed Sensex today.The said drug is a generic version of Decogen available in USA and other countries.This is used to make immature blood cells in bone marrow, healthy. Drug''s manufacturing facility is located near Hyderabad. Founder Chairman of the company that is producing the drug, Dr.Habil Khorakiwala said that the drug was an add-on in growing portfolio of cancer drugs. Wockhardt will be launching this product in the United States, in a short period of time. Wockhardt Ltd is currently trading at Rs425 up by Rs28.95 or 7.31 percent from its previous closing of Rs396.05 on the BSE. Hindusthan Samachar/Bharati/Pramod \
लोकप्रिय खबरें
फोटो और वीडियो गैलरी